Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Faecal microbiota transplantation is an emerging therapeutic option, particularly for the treatment of recurrent Clostridioides difficile infection. Stool banks that organise recruitment and screening of faeces donors are being embedded within the regulatory frameworks described in the European Union Tissue and Cells Directive and the technical guide to the quality and safety of tissue and cells for human application, published by the European Council.

Objective: Several European and international consensus statements concerning faecal microbiota transplantation have been issued. While these documents provide overall guidance, we aim to provide a detailed description of all processes that relate to the collection, handling and clinical application of human donor stool in this document.

Methods: Collaborative subgroups of experts on stool banking drafted concepts for all domains pertaining to stool banking. During a working group meeting in the United European Gastroenterology Week 2019 in Barcelona, these concepts were discussed and finalised to be included in our overall guidance document about faecal microbiota transplantation.

Results: A guidance document for all domains pertaining to stool banking was created. This document includes standard operating manuals for several processes involved with stool banking, such as handling of donor material, storage and donor screening.

Conclusion: The implementation of faecal microbiota transplantation by stool banks in concordance with our guidance document will enable quality assurance and guarantee the availability of donor faeces preparations for patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259288PMC
http://dx.doi.org/10.1177/2050640620967898DOI Listing

Publication Analysis

Top Keywords

stool banking
20
faecal microbiota
20
microbiota transplantation
16
guidance document
12
stool
8
working group
8
stool banks
8
tissue cells
8
domains pertaining
8
pertaining stool
8

Similar Publications

Parity influences on the infant gut microbiome development: a longitudinal cohort study.

Gut Microbes

December 2025

Clinical Microbiome Unit, Laboratory of Host Immunity and Microbiome, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, MD, USA.

Parity, the number of pregnancies carried beyond 20 weeks, influences the maternal gut microbiome. However, whether parity modulates the infant microbiome longitudinally remains underexplored. To address this, 746 infants in a longitudinal cohort study were assessed.

View Article and Find Full Text PDF

High prevalence of multi-drug-resistant bacteria in faecal samples from UK passerine birds.

Sci Rep

August 2025

School of Life and Environmental Sciences, University of Lincoln, Joseph Banks Laboratories, Green Lane, Lincoln, LN6 7DL, UK.

Wild birds are a near ubiquitous sight in gardens, offering pleasure to many people through supplementary feeding, song, or other interactions. However, they are also potential carriers of many bacteria, including Campylobacter spp., Salmonella spp.

View Article and Find Full Text PDF

Preterm infants experience abnormal microbial colonization, which coupled with their vulnerable physiology can increase the risk of disease. Understanding the factors influencing the complex relationship between the temporal development of the gut microbiome and functional metabolites derived from microbe-microbe and microbe-host interaction is therefore critical. In this study, 266 longitudinal stool samples from 66 very preterm infants underwent 16S rRNA gene sequencing to analyse gut microbial structure.

View Article and Find Full Text PDF

Background: Cholera is endemic in Uganda with cases reported annually. On July 19, 2023, the Uganda Ministry of Health declared a cholera outbreak in Kayunga District following death of four family members within eight days and confirmation of Vibrio cholerae by culture. We investigated the outbreak to determine the magnitude and its mode of transmission and generate evidence to inform interventions.

View Article and Find Full Text PDF

Donor-centric administration of the stool donor program is vital to its feasibility and patient safety.

Gut Microbes

December 2025

Division of Gastroenterology, Hepatology, and Nutrition, Microbiota Therapeutics Program, University of Minnesota, Minneapolis, MN, USA.

Human stool-based products composed of fecal microbiota are a new frontier of medical therapeutics development. The development of standardized manufacturing protocols of donor microbiota has transformed fecal microbiota transplantation (FMT) from a crude and rarely used procedure to a widely accepted and highly effective option for treatment infections. There is also a growing interest in using microbiota transplant therapies for multiple other clinical indications.

View Article and Find Full Text PDF